Centene Corporation $CNC Shares Acquired by QV Investors Inc.

QV Investors Inc. lifted its stake in Centene Corporation (NYSE:CNC) by 21.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 361,722 shares of the company’s stock after acquiring an additional 64,680 shares during the quarter. QV Investors Inc. owned 0.07% of Centene worth $12,906,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CNC. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Centene during the third quarter worth $27,000. WPG Advisers LLC raised its holdings in shares of Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after buying an additional 282 shares during the period. Bogart Wealth LLC lifted its stake in Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after acquiring an additional 991 shares in the last quarter. Financial Network Wealth Advisors LLC grew its position in Centene by 54.9% in the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock valued at $39,000 after acquiring an additional 390 shares in the last quarter. Finally, Quent Capital LLC purchased a new stake in Centene during the third quarter worth about $45,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Performance

NYSE CNC opened at $45.33 on Friday. The company has a fifty day moving average of $40.96 and a two-hundred day moving average of $34.99. The company has a market capitalization of $22.28 billion, a PE ratio of -4.19, a P/E/G ratio of 1.03 and a beta of 0.48. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $66.81. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.08 and a quick ratio of 1.08.

Centene (NYSE:CNC) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of ($0.21) by $0.71. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The firm had revenue of $49.69 billion during the quarter, compared to the consensus estimate of $47.50 billion. During the same quarter in the prior year, the firm earned $1.62 EPS. Centene’s revenue for the quarter was up 18.2% on a year-over-year basis. As a group, analysts expect that Centene Corporation will post 6.86 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CNC has been the subject of several recent research reports. Robert W. Baird raised their price objective on shares of Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Truist Financial raised their price target on shares of Centene from $45.00 to $47.00 and gave the company a “buy” rating in a research report on Monday, January 5th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Centene in a research report on Wednesday. JPMorgan Chase & Co. lifted their target price on Centene from $38.00 to $45.00 and gave the company a “neutral” rating in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Centene from $24.00 to $32.00 in a research note on Friday, October 31st. Three equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $40.81.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.